A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients

NCT01638676 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Vemurafenib
DRUG: Metformin

Sponsor

University of Louisville

Collaborators

[object Object]